Head and Neck-Journal for the Sciences and Specialties of the Head and

Papers
(The H4-Index of Head and Neck-Journal for the Sciences and Specialties of the Head and is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information94
55
Issue Information49
Initial Proof‐of‐Concept Study on Immediate Effects of External Advanced Pneumatic Compression on Pharyngeal and Laryngeal Internal Lymphedema Using a Fluoroscopic Measurement Tool42
Deconstructive versus reconstructive approach to internal carotid artery blowout in radiated nasopharyngeal carcinoma: A tertiary center experience and systematic review40
Financial (dis)incentives to surgical management of head and neck cancer care34
A Real‐World Phase IV Superiority Trial and Cost‐Effectiveness Analysis of the Addition of Low‐Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regime31
Prognostic value of hypothyroidism in patients undergoing intensity‐modulated radiation therapy for nasopharyngeal carcinoma31
Anatomy and Histology of Sensorimotor Connections Between the Facial and Trigeminal Nerve in the Buccinator Muscle30
Carboplatin and paclitaxel after anti‐PD‐1 or anti‐PD‐L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck29
Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma26
Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies25
Risk factors associated with prognosis of patients with medication‐related osteonecrosis of the jaw24
Evaluation of subclasses for T4‐classified squamous cell carcinoma of the external auditory canal24
A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer24
PET/CTversus triple endoscopy in initial workup ofHPV+ oropharyngeal squamous cell carcinoma24
Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers24
Impact of a prognostic model for overall survival on the decision‐making process in a head and neck cancer multidisciplinary consultation meeting24
Clinical outcome of salvage surgery in patients with recurrent oral cavity cancer: A systematic review and meta‐analysis24
African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer23
18F‐fludeoxyglucose positron emission computed tomography (18F‐FDG‐PET/CT) versus 68Ga‐DOTATATE‐PET/CT in patien23
Deriving prognostic significance from a molecular subtype model of laryngeal carcinoma23
Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis22
Microvascular surgery using surgical loupes versus operating microscope—A single head and neck reconstructive surgeon's experience22
0.087195873260498